The Effect of Vericiguat on Peripheral Vascular Function, Patient Health Status and Inflammation

Clinical trial NCT05420012 · COMPLETED

Trial details

NCT number: NCT05420012
Sponsor: Josef Stehlik
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Heart Failure Heart Failure With Reduced Ejection Fraction (HFrEF)

Start date: 2023-05-01
Primary completion: 2024-10-24
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.